Disease Burden, Patient Experiences, and Unmet Needs in Those With Rheumatoid Arthritis Initiating a Third Advanced Therapy: Insights From 20 Years of Real‐World Data
Exposure to three advanced RA therapies was associated with significant disease burden and unmet health care needs. These findings underscore the importance of well-defined refractory criteria and the need for further investigation into this RA phenotype to identify targeted treatment strategies and ultimately improve outcomes.
Authors
- Sofia Pedro
- Kaleb D. Michaud (ORCID: https://orcid.org/0000-0002-5350-3934)
- U. Sbarigia (ORCID: https://orcid.org/0000-0003-3303-2554)
- Bobby Kwanghoon Han (ORCID: https://orcid.org/0000-0002-6492-8487)
- Federico Zazzetti
- Kristin Wipfler (ORCID: https://orcid.org/0000-0001-8137-8117)
- Patti Katz
- Anna Sheahan
Institutions
- Johnson & Johnson (United States) (US)
- University of California, San Francisco (US)
- University of Washington (US)
- The National Databank for Rheumatic Diseases (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- ACR Open Rheumatology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/acr2.70180
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00